• MediciNova (MNOV) disclosed a sale of 640,000 common shares on Sept. 25, 2026 by 3D Investment Partners.
• The shares were sold at USD 2.70 each, cutting beneficial ownership to 4,862,047 shares held indirectly via 3D Opportunity Master Fund.
• The filer was listed as a former 10% owner.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. MediciNova Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-104739), on September 29, 2026, and is solely responsible for the information contained therein.